Friday Pop Quiz 6/19/2026
This patient also has extensive oral erosions. He tells you his only new medication is dicloxacillin, which he is taking for impetigo. How many days prior to development of the pictured eruption did this patient most likely begin taking dicloxacillin?
A. Hours-2 days
B. 7-21 days
C. 21-56 days
D. 60-90 days
E. >180 days
To find out the correct answer and read the explanation …
This patient also has extensive oral erosions. He tells you his only new medication is dicloxacillin, which he is taking for impetigo. How many days prior to development of the pictured eruption did this patient most likely begin taking dicloxacillin?
A. Hours-2 days
B. 7-21 days
C. 21-56 days
D. 60-90 days
E. >180 days
To find out the correct answer and read the explanation … 
Inpatient dermatologic consultations require expert care to make a prompt and accurate diagnosis. For best practices, Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Watch as Dr. Sokumbi shares the three categories you need to consider in your initial exam of an … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kalyani Marathe, director of the dermatology division at Cincinnati Children’s Hospital. Dr. Marathe shares serious pediatric skin issues including infections, drug reactions and congenital conditions. Watch and learn how to recognize and treat these serious issues, and how to know whe … 
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes … 
INTRODUCTION
Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …